{"entity":{"type":"insider","cik":"0001497725","url":"/insider/0001497725","json_url":"/insider/0001497725.json","name":"Quaker BioVentures II LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":5,"first":"2011-02-17","last":"2019-11-13","span_basis":"filed_date"},"name_variants":[{"name":"Quaker BioVentures II LP","source":"filing","n_filings":5,"first_seen":"2011-02-17","last_seen":"2019-11-13"}],"transactions":[{"id":8150498,"accession":"0001192482-19-000430","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-19-000430","line_url":"/filing/0001192482-19-000430#line-1","is_derivative":false,"issuer_cik":"0001497725","issuer_name":"TELA Bio, Inc.","issuer_ticker":"TELA","issuer_name_source":null,"issuer_url":"/issuer/0001497725","owner_cik":null,"owner_name":"Quaker BioVentures Capital II, L.P.; Quaker BioVentures II LP","owner_display_name":"Quaker BioVentures Capital II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":153846.0,"shares_display":"153,846","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":1999998.0,"total_display":"1,999,998.00","total_whole":"1,999,998","shares_owned_after":888664.0,"shares_owned_after_display":"888,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-08","filed_date":"2019-11-13","scope":"insider"},{"id":4633717,"accession":"0001192482-13-000154","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-13-000154","line_url":"/filing/0001192482-13-000154#line-1","is_derivative":false,"issuer_cik":"0001461993","issuer_name":"CEMPRA, INC.","issuer_ticker":"CEMP","issuer_name_source":null,"issuer_url":"/issuer/0001461993","owner_cik":null,"owner_name":"Quaker BioVentures II LP; Quaker BioVentures Capital II, L.P.","owner_display_name":"Quaker BioVentures II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":265000.0,"shares_display":"265,000","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":1855000.0,"total_display":"1,855,000.00","total_whole":"1,855,000","shares_owned_after":3527154.0,"shares_owned_after_display":"3,527,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-19","filed_date":"2013-08-01","scope":"insider"},{"id":8943338,"accession":"0001192482-11-000051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-11-000051","line_url":"/filing/0001192482-11-000051#line-1","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":"0001497725","owner_name":"Quaker BioVentures II LP","owner_display_name":"Quaker BioVentures II LP","owner_url":"/insider/0001497725","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200822.0,"shares_display":"200,822","price_per_share":5.99,"price_display":"5.99","price_state":"stated","total_value":1202923.78,"total_display":"1,202,923.78","total_whole":"1,202,924","shares_owned_after":4278029.0,"shares_owned_after_display":"4,278,029","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-07","filed_date":"2011-03-09","scope":"insider"},{"id":8943337,"accession":"0001192482-11-000046","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001192482-11-000046","line_url":"/filing/0001192482-11-000046#line-3","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":"0001497725","owner_name":"Quaker BioVentures II LP","owner_display_name":"Quaker BioVentures II LP","owner_url":"/insider/0001497725","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66300.0,"shares_display":"66,300","price_per_share":5.9242,"price_display":"5.92","price_state":"stated","total_value":392774.46,"total_display":"392,774.46","total_whole":"392,774","shares_owned_after":4478851.0,"shares_owned_after_display":"4,478,851","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-03","filed_date":"2011-03-03","scope":"insider"},{"id":8943335,"accession":"0001192482-11-000046","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-11-000046","line_url":"/filing/0001192482-11-000046#line-2","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":"0001497725","owner_name":"Quaker BioVentures II LP","owner_display_name":"Quaker BioVentures II LP","owner_url":"/insider/0001497725","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57500.0,"shares_display":"57,500","price_per_share":5.8977,"price_display":"5.90","price_state":"stated","total_value":339117.75,"total_display":"339,117.75","total_whole":"339,118","shares_owned_after":4545151.0,"shares_owned_after_display":"4,545,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-02","filed_date":"2011-03-03","scope":"insider"},{"id":8943333,"accession":"0001192482-11-000046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-11-000046","line_url":"/filing/0001192482-11-000046#line-1","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":"0001497725","owner_name":"Quaker BioVentures II LP","owner_display_name":"Quaker BioVentures II LP","owner_url":"/insider/0001497725","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":5.8768,"price_display":"5.88","price_state":"stated","total_value":587680.0,"total_display":"587,680.00","total_whole":"587,680","shares_owned_after":4602651.0,"shares_owned_after_display":"4,602,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-01","filed_date":"2011-03-03","scope":"insider"},{"id":8848200,"accession":"0001192482-11-000041","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001192482-11-000041","line_url":"/filing/0001192482-11-000041#line-3","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":"0001497725","owner_name":"Quaker BioVentures II LP","owner_display_name":"Quaker BioVentures II LP","owner_url":"/insider/0001497725","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6787.0,"shares_display":"6,787","price_per_share":5.08,"price_display":"5.08","price_state":"stated","total_value":34477.96,"total_display":"34,477.96","total_whole":"34,478","shares_owned_after":4702651.0,"shares_owned_after_display":"4,702,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-17","filed_date":"2011-02-17","scope":"insider"},{"id":8848198,"accession":"0001192482-11-000041","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-11-000041","line_url":"/filing/0001192482-11-000041#line-2","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":"0001497725","owner_name":"Quaker BioVentures II LP","owner_display_name":"Quaker BioVentures II LP","owner_url":"/insider/0001497725","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":5.08,"price_display":"5.08","price_state":"stated","total_value":381000.0,"total_display":"381,000.00","total_whole":"381,000","shares_owned_after":4709438.0,"shares_owned_after_display":"4,709,438","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-16","filed_date":"2011-02-17","scope":"insider"},{"id":8848195,"accession":"0001192482-11-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-11-000041","line_url":"/filing/0001192482-11-000041#line-1","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":"0001497725","owner_name":"Quaker BioVentures II LP","owner_display_name":"Quaker BioVentures II LP","owner_url":"/insider/0001497725","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":5.07,"price_display":"5.07","price_state":"stated","total_value":380250.0,"total_display":"380,250.00","total_whole":"380,250","shares_owned_after":4784438.0,"shares_owned_after_display":"4,784,438","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-15","filed_date":"2011-02-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001561921","name":"TELA Bio, Inc.","url":"/issuer/0001561921","role":"Ten percent owner","n_filings":1,"first_seen":"2019-11-13","last_seen":"2019-11-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001461993","name":"CEMPRA, INC.","url":"/issuer/0001461993","role":"Ten percent owner","n_filings":1,"first_seen":"2013-08-01","last_seen":"2013-08-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001070336","name":"ACHILLION PHARMACEUTICALS INC","url":"/issuer/0001070336","role":"Ten percent owner","n_filings":3,"first_seen":"2011-02-17","last_seen":"2011-03-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001497725","retrieved_at":"2026-08-27T05:52:25+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}